Bacterial Mix Enhances Immunotherapy Response.
Researchers have isolated a mix of 11 strains of bacteria that increase the effectiveness of checkpoint inhibitors in mice. The bacteria boosted IFNγ+ CD8+ T-cell counts and enhanced anti-PD-1 and anti-CTLA4 treatments in mice implanted with colon cancer or melanoma cells, findings that could have implications for patient care.